TR201906742T4 - Tıbbi bir ürün ve tedavi. - Google Patents

Tıbbi bir ürün ve tedavi. Download PDF

Info

Publication number
TR201906742T4
TR201906742T4 TR2019/06742T TR201906742T TR201906742T4 TR 201906742 T4 TR201906742 T4 TR 201906742T4 TR 2019/06742 T TR2019/06742 T TR 2019/06742T TR 201906742 T TR201906742 T TR 201906742T TR 201906742 T4 TR201906742 T4 TR 201906742T4
Authority
TR
Turkey
Prior art keywords
ibuprofen
paracetamol
patients
pain
treatment
Prior art date
Application number
TR2019/06742T
Other languages
English (en)
Turkish (tr)
Inventor
Campbell Atkinson Hartley
Original Assignee
Aft Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42106693&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR201906742(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aft Pharmaceuticals Ltd filed Critical Aft Pharmaceuticals Ltd
Publication of TR201906742T4 publication Critical patent/TR201906742T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
TR2019/06742T 2008-10-14 2009-10-12 Tıbbi bir ürün ve tedavi. TR201906742T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ56961208 2008-10-14

Publications (1)

Publication Number Publication Date
TR201906742T4 true TR201906742T4 (tr) 2019-05-21

Family

ID=42106693

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2019/06742T TR201906742T4 (tr) 2008-10-14 2009-10-12 Tıbbi bir ürün ve tedavi.
TR2011/02810T TR201102810T2 (tr) 2008-10-14 2009-10-12 Tıbbi bir ürün ve tedavi

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2011/02810T TR201102810T2 (tr) 2008-10-14 2009-10-12 Tıbbi bir ürün ve tedavi

Country Status (29)

Country Link
US (1) US20110166234A1 (OSRAM)
EP (1) EP2341900B1 (OSRAM)
JP (1) JP2012505830A (OSRAM)
KR (1) KR20110112279A (OSRAM)
CN (1) CN102215835A (OSRAM)
AU (1) AU2009304002B9 (OSRAM)
BR (1) BRPI0914086A2 (OSRAM)
CA (1) CA2735834C (OSRAM)
CH (1) CH702339B1 (OSRAM)
CL (1) CL2011000678A1 (OSRAM)
CO (1) CO6341553A2 (OSRAM)
CY (1) CY1122198T1 (OSRAM)
DK (1) DK2341900T3 (OSRAM)
ES (1) ES2725151T3 (OSRAM)
GB (1) GB2476418B (OSRAM)
HR (1) HRP20190891T1 (OSRAM)
HU (1) HUE043063T2 (OSRAM)
LT (1) LT2341900T (OSRAM)
MA (1) MA32635B1 (OSRAM)
MX (1) MX340662B (OSRAM)
MY (1) MY153932A (OSRAM)
NZ (1) NZ591496A (OSRAM)
PL (1) PL2341900T3 (OSRAM)
PT (1) PT2341900T (OSRAM)
RU (1) RU2487707C2 (OSRAM)
SI (1) SI2341900T1 (OSRAM)
TR (2) TR201906742T4 (OSRAM)
WO (1) WO2010044681A1 (OSRAM)
ZA (1) ZA201101752B (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2431346C (en) 2004-07-07 2010-02-17 Aft Pharmaceuticals Ltd A combination composition comprising paracetamol and ibuprofen
MX367209B (es) * 2010-11-04 2019-07-22 Aft Pharmaceuticals Ltd Una composición intravenosa que comprende ibuprofeno y paracetamol en combinación.
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
US10376471B2 (en) * 2017-07-10 2019-08-13 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0109281A1 (en) * 1982-11-15 1984-05-23 The Upjohn Company Compositions comprising flurbiprofen or ibuprofen
ZA837556B (en) * 1982-11-15 1984-06-27 Upjohn Co Acetominophen and ibuprofen/flurbiprofen
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
CA1336687C (en) * 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
GB2431346C (en) * 2004-07-07 2010-02-17 Aft Pharmaceuticals Ltd A combination composition comprising paracetamol and ibuprofen
GB0519350D0 (en) * 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method

Also Published As

Publication number Publication date
WO2010044681A1 (en) 2010-04-22
NZ591496A (en) 2012-12-21
CN102215835A (zh) 2011-10-12
RU2011111792A (ru) 2012-11-27
GB2476418A (en) 2011-06-22
HUE043063T2 (hu) 2019-07-29
US20110166234A1 (en) 2011-07-07
AU2009304002B9 (en) 2014-06-26
EP2341900A1 (en) 2011-07-13
EP2341900B1 (en) 2019-02-20
GB201105249D0 (en) 2011-05-11
CH702339B1 (de) 2016-06-15
PT2341900T (pt) 2019-05-14
RU2487707C2 (ru) 2013-07-20
MY153932A (en) 2015-04-15
DK2341900T3 (da) 2019-05-20
CY1122198T1 (el) 2020-11-25
ES2725151T3 (es) 2019-09-19
CA2735834A1 (en) 2010-04-22
GB2476418B (en) 2013-04-24
SI2341900T1 (sl) 2019-06-28
BRPI0914086A2 (pt) 2020-01-21
CL2011000678A1 (es) 2011-09-23
CO6341553A2 (es) 2011-11-21
AU2009304002A1 (en) 2010-04-22
LT2341900T (lt) 2019-04-10
EP2341900A4 (en) 2012-02-29
JP2012505830A (ja) 2012-03-08
HRP20190891T1 (hr) 2019-07-12
AU2009304002B2 (en) 2013-04-18
KR20110112279A (ko) 2011-10-12
CA2735834C (en) 2017-05-16
MX2011003928A (es) 2011-08-12
MX340662B (es) 2016-07-20
TR201102810T2 (tr) 2011-05-23
PL2341900T3 (pl) 2019-08-30
ZA201101752B (en) 2012-02-29
MA32635B1 (fr) 2011-09-01

Similar Documents

Publication Publication Date Title
JP7590803B2 (ja) 経皮カンナビジオールゲルを用いた変形性関節症の治療方法
Gruenthal et al. Gabapentin for the treatment of spasticity in patients with spinal cord injury
US6689399B1 (en) Transdermal delivery of an anti-inflammatory composition
KR20200055067A (ko) 성인의 초점성 뇌전증의 치료를 위한 합성 경피성 칸나비디올
TR201906742T4 (tr) Tıbbi bir ürün ve tedavi.
Oh et al. Comparative analysis of intra-articular injection of steroid and/or sodium hyaluronate in adhesive capsulitis: prospective, double-blind, randomized, placebo-controlled study
US20100226972A1 (en) Transdermal pain gel
MX2013005113A (es) Una composicion combinada.
RU2616520C2 (ru) Лечение симптомов, связанных с гастропарезом у женщин
Agarwal et al. Gabapentin enacarbil–clinical efficacy in restless legs syndrome
US20140037718A1 (en) Transdermal pain gel
Polacco et al. The effect of intra-articular hyaluronic acid (Sinovial® One) on knee osteoarthritis: A preliminary study
CN104906501A (zh) 治疗银屑病的中药组分组合物
WO2000050028A1 (en) Compositions for the treatment of pain
Evcik et al. The efficacy of intra-articular tenoxicam in the treatment of knee osteoarthritis
Saha et al. Role of Glucosamine Sulphate, Chrondoitin Sulphate and Vitamin C in the management of pain in Osteoarthritis
Hohn et al. Effects of dextromethorphan on postoperative pain after orthopedic surgery under spinal anesthesia
Oates Complementary medicines for musculoskeletal conditions
Allison Treatment of plantar fasciitis by low-Dye taping and iontophoresis–short-term results of a double blinded, randomised, placebo controlled clinical trial of dexamethasone and acetic acid.
CN108883056A (zh) 用于治疗外周关节、脊柱关节和/或结缔组织的细胞外基质元件的制剂、制造方法和用途
WO2016092377A2 (ru) Композиция, содержащая глюкозамин, фруктобарат кальция и витамин d для лечения и/или профилактики нарушений, связанных с воспалительными заболеваниями суставов, её применение и способ лечения и/или профилактики нарушений, связанных с воспалительными заболеваниями суставов и позвоночника